EGFR and glioblastoma: EGFR-amplified/mutant human GBMs express a high amount of YAP and VP, an inhibitor of the YAP-TEAD complex, is capable to induce apoptosis in patient-derived EGFR- /mutant GBM because it can suppress expression of YAP/TAZ transcriptional targets, including EGFR.